Renaissance Technologies’s HUMANIGEN, INC. HGEN Stock Holding History

Renaissance Technologies’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,200	Closed	-$3K	–	4297
2023 Q2	$3K	Sell	18,200 -79,500	-81%	-$12.4K	﹤0.01%	3861
2023 Q1	$14K	Sell	97,700 -1,394,071	-93%	-$223K	﹤0.01%	3868
2022 Q4	$179K	Buy	1,491,771 +626,071	+72%	+$90.3K	﹤0.01%	3457
2022 Q3	$156K	Buy	+865,700	New	+$466K	﹤0.01%	3463

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Renaissance Technologies's HGEN Position: Q3 2023 in Review

Renaissance Technologies sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 18,200 shares — an estimated $3K sold.

Renaissance Technologies first reported a position in HGEN in Q3 2022 and held it in 4 quarters. The position peaked at $179K in Q4 2022. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Renaissance Technologies reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 18,200 HUMANIGEN, INC. shares in Q3 2023, an estimated $3K.
Renaissance Technologies first reported a position in HUMANIGEN, INC. in Q3 2022 and held it in 4 quarters.
Renaissance Technologies's HUMANIGEN, INC. position peaked at $179K in Q4 2022.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.